3SBio
Sell5.40
Spread0.15
Buy5.55

Trade 3SBio Inc. - 1530 stock price

Sell5.40
Spread0.15
Buy5.55
1m
5m
15m
30m
1H
4H
1D
1W
History
3SBio Inc. develops, manufactures, markets, and sells biopharmaceuticals. The company's primary products include TPIAO, a recombinant human thrombopoietin for thrombocytopenia; Yisaipu, a tumour necrosis factor for treating rheumatoid arthritis, ankylosing spondylitis, and psoriasis; and EPIAO, a recombinant human erythropoietin for the treatment of anemia associated with chronic kidney disease (CKD), chemotherapy-induced anemia, and reduction of allogeneic blood transfusion in surgery patients. Its primary products also comprise SEPO, a recombinant human erythropoietin for anemia associated with CKD and chemotherapy; Byetta/Bydureon, an exenatide injection to improve glycemic control in adults with type-2 diabetes mellitus; and Qiming Keli for retinopathy caused by type-2 diabetes. In addition, the company offers Ruisiyi to treat advanced breast cancer; Wanwei for treating vomiting caused by cytotoxic chemotherapy; and Intefen to treat lymphatic or hematopoietic malignancies and viral infections. Further, it provides Inleusin for renal cell carcinoma, melanoma, thoracic fluid build-up caused by cancer, and tuberculosis; Etanercept for moderate to severe rheumatoid arthritis and plaque psoriasis, and active ankylosing spondylitis; and Sparin for prophylaxis and vein thrombosis, and to prevent clotting during hemodialysis. Additionally, the company offers Mandi for male-pattern alopecia and alopecia areata; Aiyishu for iron-deficiency anemia; Disu to prevent and treat chronic bronchitis, colds, and asthma; Jiannipai to prevent acute rejection after renal transplantation; and Humulin for diabetes, as well as contract development and manufacturing, trading, project management and consultation, and technology services. The company markets its products through in-house sales and marketing team, as well as distributors and third-party promoters. 3SBio Inc. was incorporated in 2006 and is headquartered in Shenyang, the People's Republic of China.
White Paper Declaration

Trade the world’s top tokenised stocks, indices, commodities and currencies with the help of crypto or fiat

Articles
Binance expands VIP program to attract traditional asset holders
BlackRock to launch Bitcoin ETF in Brazil
Hackers drained over $100m across 20 attacks in February, data shows
Crypto bulls take aim at US politics with $80m war chest
1 BTC
Invest
50 BTC
Profit
Leverage:
x50

The Power Of Leverage

Trade in the big leagues with 100 Bitcoin for every 1 Bitcoin you put in

1530 price history

Date Close Change Chg% Open Min. Max.
2022-09-30 5.4 -0.05 -0.92 5.45 5.2 5.55
2022-09-30 5.4 0.05 0.93 5.35 5.35 5.45
2022-09-30 5.45 0.05 0.93 5.4 5.25 5.45
2022-09-30 5.4 -0.05 -0.92 5.45 5.4 5.55
2022-09-30 5.5 0.10 1.85 5.4 5.35 5.55
2022-09-30 5.4 0.10 1.89 5.3 5.15 5.4
2022-09-30 5.25 -0.10 -1.87 5.35 5.25 5.35
2022-09-30 5.35 -0.05 -0.93 5.4 5.35 5.45
2022-09-30 5.4 0.05 0.93 5.35 5.3 5.45
2022-09-30 5.4 0.10 1.89 5.3 5.3 5.45
2022-09-30 5.4 0.10 1.89 5.3 5.3 5.45
2022-09-30 5.3 0.10 1.92 5.2 5.2 5.3
2022-09-30 5.25 -0.25 -4.55 5.5 5.15 5.5
2022-09-30 5.6 0.25 4.67 5.35 5.35 5.6
2022-09-30 5.45 0.05 0.93 5.4 5.2 5.45
2022-09-30 5.35 0.25 4.90 5.1 4.95 5.4
2022-09-30 5.1 -0.05 -0.97 5.15 5.1 5.2
2022-09-30 5.15 -0.15 -2.83 5.3 5.1 5.3
2022-09-30 5.25 0.05 0.96 5.2 5.15 5.3
2022-09-30 5.2 0.10 1.96 5.1 5.05 5.2
Go help.dzengi.com